Hologic shares cease trading, delisted from Nasdaq after Blackstone-TPG buyout

Hologic
Blackstone Inc.

Hologic

HOLX

0.00

Blackstone Inc.

BX

0.00
  • Hologic common stock ceased trading and was delisted from Nasdaq following completion of its acquisition by funds managed by Blackstone and TPG.
  • Deal valued at up to $79 per share, taking Hologic private.
  • Stockholders will receive $76 per share in cash and a non-tradable CVR worth up to $3 per share tied to Breast Health global revenue goals in fiscal 2026 and 2027.
  • José (Joe) E. Almeida appointed chief executive officer effective immediately, succeeding Stephen MacMillan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260406579333) on April 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.